🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07073443
Active, not recruiting Not applicable

Evaluation of the Effect of Memory-based Reminiscence Therapy

NCT07073443 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-06-15
Last updated
2025-07-18

Condition(s) studied

DementiaMemory, Short-Term

Investigational drug(s) / intervention(s)

Experimental: Memory Therapy Group

Experimental: Memory Therapy Group: Evaluation of the Effect of Memory-Based Recall Therapy on the Cognitive Status, Psychological Flexibility, and Cognitive Flexibility of Elderly Individuals Diagnosed with Dementia

Study summary

The main objective of this study is to examine the effects of memory-based recall therapy applied to elderly adults diagnosed with Stage 0, 1, and 2 dementia on their mental state, psychological flexibility, and cognitive flexibility.

The original flow plan created in the study is not found in the literature. Therefore, presenting the effects of memory-based recall on cognition in the literature may demonstrate that the contents of classical recall therapy can also be effectively restructured with cognitive effects. From this perspective, the aim is to make recommendations for "advanced psychiatric nursing practices."

Research Hypotheses:

H0: Memory-based recall therapy has no effect on mental state, psychological flexibility, and cognitive flexibility in individuals with early-stage dementia.

H1: Memory-based Recall Therapy has an effect on mental state, psychological flexibility, and cognitive flexibility in individuals with early-stage dementia.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Receiving outpatient treatment for dementia from the relevant departments of hospitals * At the time of the interviews, the doctor must have diagnosed mild dementia. (Stages 0, 1, and 2) * No problems with understanding or speaking Turkish * Being literate * Being in the 65 and older age group * No other psychiatric or neurological disorders Exclusion Criteria: * Not having been diagnosed with dementia during the study * Having other chronic cognitive and psychiatric illnesses * Being in an advanced stage of dementia * Those who withdrew from the study during the interview or refused to participate in the study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Kahramanmaraş Istiklal Universty Kahramanmaraş Turkey (Türkiye)

More Kahramanmaraş İstiklal University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07073443 on ClinicalTrials.gov ↗ ← All trials in Turkey